TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
planned
Official procurement procedure

Purchase, Storage and Emergency Production of Foot and Mouth Antigen and Vaccine

Vaccines for veterinary medicine
UK
Published value
£4,300,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: ANIMAL AND PLANT HEALTH AGENCY: "Purchase, Storage and Emergency Production of Foot and Mouth Antigen and Vaccine". Published status: planned. Published value: £4,300,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityANIMAL AND PLANT HEALTH AGENCYScope & CategoriesNot publishedSubmission Window
planned
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£4,300,000
Bidder Intelligence · Authority Profile: ANIMAL AND PLANT HEALTH AGENCY
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for ANIMAL AND PLANT HEALTH AGENCY. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationHigh Concentration
Bruker UK LimitedTop vendor: 100% of attributable value
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 77 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
Supplier NameHistoric AwardsAttributable GBP Value
Bruker UK Limited1 win£750,000
Procedure terms
Contracting AuthorityANIMAL AND PLANT HEALTH AGENCY
Procedure methodNot published
Procurement categoryNot published
Statusplanned
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published15 Jul 2026, 15:14 BST
Last source update15 Jul 2026, 15:14 BST
Recurring procurementNot published
ClassificationVaccines for veterinary medicine
Delivery area
UK
OCIDocds-h6vhtk-06c506
What is being bought
A UK2 notice (UK-0329) was published on 08/08/2025, containing the same details as below. Since then, the scope has been further developed, and we are re-engaging with the market to obtain the most current information before proceeding to competitive tender. Defra is exploring options for supply of antigen and vaccines to the UK foot and mouth disease (FMD) vaccine bank and is seeking to identify existing and potential suppliers who have FMD vaccines with robust evidence of quality, safety, and efficacy. We are keen to hear from suppliers who are in a position to supply suitable FMD vaccine products from early 2028 (including manufacturing lead times as necessary). Please provide the information detailed in the section below, but please note that Defra will not consider heterologous vaccine products. Those wishing to provide the information requested here should contact Melanie Swain (melanie.swain@defra.gov.uk), by 24th July 2026. Defra reserves the right to follow up with suppliers on a 1:1 basis to further understand their capabilities with regard to this requirement. Defra is seeking this information to inform decisions around guarantees of supply to the UK market. Therefore the estimated total value shown below is only indicative at this stage.
What changed
From the official release history
  1. Official notice release published
    15 Jul 2026, 15:14 BST
  2. Published value updated to £4,300,000
    7 Jul 2026, 11:55 BST
  3. Status changed to planned
    7 Jul 2026, 11:55 BST
  4. Official notice release published
    7 Jul 2026, 11:55 BST
  5. Buyer information updated
    7 Jul 2026, 11:55 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    planned
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Pipeline notice
    15 Jul 2026, 15:14 BST
  2. Procedure published
    15 Jul 2026, 15:14 BST
  3. engagement
    24 Jul 2026, 23:59 BST · scheduled
    If your organisation is interested in this requirement (and did not respond to the UK2 notice in 2025), please provide the following information to the named contact above, via email: - The details of your organisation's FMD antigen and vaccine products. - Number and size of dose. - Data on safety, efficacy and period (onset and duration) of immunity in the target species. - Longevity/shelf life of vaccines and antigen. - The number of doses in the vaccination schedule. - Storage conditions and bottle sizes available. - The type of technology used to develop the vaccine production capacity. - Species that can be vaccinated and any data on the minimum age that animals can be vaccinated. - Whether the vaccine is produced to GMP standard or equivalent. - Whether the vaccine is manufactured and stored according to the WOAH Terrestrial Manual Chapter 3.1.8. - Whether the vaccine is currently authorised for use with a valid marketing authorisation and, if so, where is the vaccine authorised. - Whether the vaccine has been used elsewhere in the world. - Timelines for submitting applications for a marketing authorisation to VMD (if relevant). - The likely cost of the product. - Information on novel technologies and products and likely timeframe to market.
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

ANIMAL AND PLANT HEALTH AGENCY

Contracting authority GB-PPON-PBHC-6261-BLLQ
View buyer profile

  • ANIMAL AND PLANT HEALTH AGENCY
    buyer

    GB-PPON: PBHC-6261-BLLQ
    Seacole Building, 2 Marsham Street, London, UKI32, SW1P 4DF, GB
    melanie.swain@defra.gov.uk

  • DEPARTMENT FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS
    procuringEntity

    GB-PPON: PNBD-3289-CDGX
    Seacole Building, 2 Marsham Street, London, UKI32, SW1P 4DF, GB
    melanie.swain@defra.gov.uk
Documents (1)
Official links; attachments are not copied
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleNot published